Telehealth
Rural hospitals, which deliver about one in 10 babies nationally each year, have been closing in significant numbers. Despite the challenging environment, rural hospitals and health systems are taking traditional and innovative approaches to build or expand their maternal health programs.
The AHA and its members are committed to promoting affordability and value to advance the health of our patients. Given the hearing’s focus of reducing health care costs, we provide comments on a number of policies aimed at increasing access to quality care at reduced costs.
In this webinar, learn how partnering with tech-enabled solutions enables you to provide affordable, scalable, customized, high-quality telemedicine care in rural communities. The right telehealth partnership can boost your ability to bridge resource gaps, augment workflows and reduce costs while…
HIPAA enforcement discretion implemented for the COVID-19 public health emergency will expire with the end of the PHE on May 11, but covered health care providers will have until Aug. 9 to comply with the HIPAA rules with respect to telehealth, the Department of Health and Human Services’ Office…
Medicare patients who have access to telehealth services and medications for opioid use disorder have lower risk of fatal drug overdose, according to a study reported yesterday in JAMA Psychiatry.
AHA's feedback on a Drug Enforcement Administration proposed rule for the telemedicine prescribing of controlled substances when there has not been a prior in-person medical evaluation.
AHA responds to the RFI on the drivers of health care workforce shortages and solutions.
Brian W. Anthony, director of MIT’s master of engineering in manufacturing program and co-director of MIT’s Medical Electronic Device Realization Center, recently outlined in MedCity News key ways that remote patient monitoring could improve health care.
The Drug Enforcement Administration (DEA) Feb. 27 published two proposed rules: telemedicine prescribing of controlled substances when there has not been a prior in-person evaluation, and expansion of buprenorphine prescribing. Comments on both rules are due to the agency by March 31
The Drug Enforcement Administration Friday proposed limiting telehealth prescriptions for buprenorphine and other controlled substances after the COVID-19 public health emergency to a 30-day supply unless the prescriber or referring clinician have evaluated the patient in person. DEA will accept…